PHARMA has a +defined/validated/fair #businessmodel. Sub-licensing assesses opportunity by peak sales of the drug and anticipates revenue + royalties for #bioprospecting. Future contracts finance development. The risk of each stages is mapped. It can be improved, but it's good.4⃣